Literature DB >> 391007

Effects of BCG, levamisole and PS-K on the rejection of male skin grafts by female mice.

S Seo, J Yasuhara, K Saeki.   

Abstract

Rejection of male skin grafts by BALB/c female mice was accelerated by one s.c. injection of BCG (5 X 10(5) microorganisms/mouse) into recipients on the day of transplantation. Levamisole 20 mg/kg injected similarly was without any effect. Protein-bound polysaccharide Kureha (PS-K) injected 250 mg/kg s.c. or i.p. once every other day from the day of transplantation stimulated graft rejection. The s.c. route was more effective than the i.p. route. These results show that, in sex-linked graft rejection in mice, PS-K has an immunostimulant action similar to that of BCG. This property may be important to the antineoplastic activity of PS-K.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 391007     DOI: 10.1007/bf01970659

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  22 in total

1.  The genetics of skin grafting.

Authors:  E J EICHWALD; C R SILMSER; N WHEELER
Journal:  Ann N Y Acad Sci       Date:  1957-03-22       Impact factor: 5.691

2.  The effect of sex on skin grafts within inbred lines of mice.

Authors:  B F SHORT; W R SOBEY
Journal:  Transplant Bull       Date:  1957-07

3.  Sex-linked rejection of normal and neoplastic tissue. I. Distribution and specificity.

Authors:  E J EICHWALD; C R SILMSER; I WEISSMAN
Journal:  J Natl Cancer Inst       Date:  1958-03       Impact factor: 13.506

Review 4.  BCG and cancer (first of two parts).

Authors:  R C Bast; B Zbar; T Borsos; H J Rapp
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

5.  Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-Guérin and neuraminidase.

Authors:  F C Sparks; J H Breeding
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

6.  Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.

Authors:  M A Chirigos; J W Pearson; J Pryor
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

7.  Effect of dose, route, and schedule of BCG on antibody titer and survival of murine skin grafts across a weak histocompatibility barrier.

Authors:  A G Wile; F C Sparks
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

Review 8.  Double-blind levamisole trial in resectable lung cancer.

Authors:  W K Amery
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

9.  BCG immunotherapy of pulmonary growths from intravenously transferred rat tumour cells.

Authors:  R W Baldwin; M V Pimm
Journal:  Br J Cancer       Date:  1973-01       Impact factor: 7.640

10.  Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.

Authors:  I Parr
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.